These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37866469)

  • 1. Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes.
    Kim ST; Xia Y; Ho JK; Lowery E; McCarthy DP; Ardehali A
    J Heart Lung Transplant; 2024 Feb; 43(2):337-345. PubMed ID: 37866469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Lung Transplantation From Hepatitis C Viremic Donors.
    Li SS; Osho A; Moonsamy P; Wolfe S; Villavicencio MA; Langer N; Sundt TM; Funamoto M
    Ann Thorac Surg; 2022 May; 113(5):1598-1607. PubMed ID: 34062125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
    Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
    Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
    Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
    J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post-transplant viremia.
    Khan S; Mazumder R; Wang X; Wang Y; Sims OT; Budev M; Carey W
    Clin Transplant; 2024 May; 38(5):e15325. PubMed ID: 38716770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor and Recipient Hepatitis C Status Does Not Affect Rejection in Thoracic Transplantation.
    Ganapathi AM; Whitson BA; Heh V; Keller BC; Smith SA; Mokadam NA; Henn MC
    Ann Thorac Surg; 2023 Jan; 115(1):221-230. PubMed ID: 35940315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the use of hepatitis C viremic donor hearts.
    Li SS; Osho A; Moonsamy P; D'Alessandro DA; Lewis GD; Villavicencio MA; Sundt TM; Funamoto M
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1873-1885.e7. PubMed ID: 33487431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Over 1000 Heart Transplants Using Hepatitis C-Positive Donors in the Modern Era.
    Kwon JH; Hill MA; Patel R; Tedford RJ; Hashmi ZA; Shorbaji K; Huckaby LV; Welch BA; Kilic A
    Ann Thorac Surg; 2023 Feb; 115(2):493-500. PubMed ID: 36368348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using HCV-viremic organs for lung transplantation does not confer higher rejection rates compared to HCV-negative organs.
    Afshar K; Schonhoft E; Kozuch J; Kafi A; Yung G; Pollema T; Golts E; Aslam S
    Clin Transplant; 2024 Feb; 38(2):e15260. PubMed ID: 38369851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non-hepatitis C-infected donors: time to revise the kidney donor profile index - a retrospective cohort study.
    Yazawa M; Balaraman V; Tsujita M; Azhar A; Talwar M; Bhalla A; Potukuchi PK; Eason JD; Kovesdy CP; Molnar MZ
    Transpl Int; 2020 Dec; 33(12):1732-1744. PubMed ID: 32935416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of lung transplantation at a Canadian center using donors declined in the United States.
    Cypel M; Yeung J; Donahoe L; Yasufuku K; Wang A; Pietroski R; Lange P; Pierre A; De Perrot M; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1661-1668.e1. PubMed ID: 35461711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.